Tissue factor activity is increased in neutrophils from <scp> JAK2 V617F </scp> ‐mutated essential thrombocythemia and polycythemia vera patients

Authors :: Rafal Pawlinski
Michael W. Henderson
Kathryn Wilson
Brandi Reeves
Soo Jin Kim
Nigel S. Key
Jihyun Song
Josef T. Prchal
Source :: American Journal of Hematology. 97
Publication Year :: 2021
Publisher :: Wiley, 2021.

Subjects :: Thrombocytosis
Neutrophils
Essential thrombocythemia
business.industry
Hematology
Janus Kinase 2
medicine.disease
Thromboplastin
Up-Regulation
Tissue factor
Polycythemia vera
medicine
Cancer research
Humans
Point Mutation
business
Blood Coagulation
Polycythemia Vera
JAK2 V617F

Full Text Access

Tools